Therefore, to initially ascertain whether CCBL2 expression levels affect BC prognosis, we studied the correlation between CCBL2 expression in BC tissues and clinicopathological characteristics, as well as with the survival status of patients with BC through analysis of The Cancer Genome Atlas-Breast Invasive Carcinoma (TCGA-BRCA) level 3 data. Here, KYAT3 is linked to breast cancer.